141 related articles for article (PubMed ID: 7923313)
1. Effects of perindopril on glucose and lipid metabolism in patients with mild-to-moderate essential hypertension and glucose intolerance.
Uchida K; Azukizawa S; Kigoshi T; Nakano S; Kaneko M; Morimoto S; Matsui A
Clin Ther; 1994; 16(3):466-70. PubMed ID: 7923313
[TBL] [Abstract][Full Text] [Related]
2. [24-hour effectiveness and tolerance of perindopril (Prestarium), an ACE inhibitor, in the treatment of mild to moderate hypertension. A 1-year Czech and Slovak study].
Widimský J; Fedelesová V; Uhlír O
Vnitr Lek; 1995 Jul; 41(7):441-4. PubMed ID: 7571476
[TBL] [Abstract][Full Text] [Related]
3. Effects of a new calcium channel blocker, MPC-1304, on blood pressure, serum lipoproteins and serum carbohydrate metabolism in patients with essential hypertension.
Sasaki J; Kajiyama G; Kusukawa R; Shichiri M; Sunaga T; Mashiba H; Tanaka N; Nonaka K; Arakawa K
Int J Clin Pharmacol Ther; 1995 Jun; 33(6):366-70. PubMed ID: 7582390
[TBL] [Abstract][Full Text] [Related]
4. [The effect of amlodipine, nifedipine and perindopril on insulin sensitivity and blood lipid of patients with essential hypertension].
Lin J; Chen D; Wu K
Zhonghua Yi Xue Za Zhi; 1998 Mar; 78(3):200-2. PubMed ID: 10923530
[TBL] [Abstract][Full Text] [Related]
5. Effects of perindopril treatment on plasma and urine of kallikrein activity and the stable metabolite of prostaglandin E2 in patients with essential hypertension.
Zacharieva S; Torbova S; Orbetzova M; Borissova AM; Andonova K; Sheitanova S
Methods Find Exp Clin Pharmacol; 1996 Apr; 18(3):205-9. PubMed ID: 8738072
[TBL] [Abstract][Full Text] [Related]
6. Renal function, glycaemic control and perindopril in diabetic patients.
Brichard S; Ketelslegers JM; Lambert AE
Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():57-61. PubMed ID: 2505714
[TBL] [Abstract][Full Text] [Related]
7. [24-hour effect and tolerance for perindopril (Prestarium) in mild and moderate essential hypertension].
Widimský J; Cihák R; Fedelesová V; Lefflerová K; Mayer O; Uhlír O
Vnitr Lek; 1992 Nov; 38(11):1066-71. PubMed ID: 1494869
[TBL] [Abstract][Full Text] [Related]
8. [The effect of urapidil on blood pressure, renal hemodynamics, lipid and glucose metabolism].
Sanjuliani AF; Fagundes VG; Francischetti EA
Arq Bras Cardiol; 1995 Jul; 65(1):59-63. PubMed ID: 8546598
[TBL] [Abstract][Full Text] [Related]
9. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
Middeke M; Richter WO; Schwandt P; Holzgreve H
Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
[TBL] [Abstract][Full Text] [Related]
10. Intrapulmonary administration of natural honey solution, hyperosmolar dextrose or hypoosmolar distill water to normal individuals and to patients with type-2 diabetes mellitus or hypertension: their effects on blood glucose level, plasma insulin and C-peptide, blood pressure and peaked expiratory flow rate.
Al-Waili N
Eur J Med Res; 2003 Jul; 8(7):295-303. PubMed ID: 12911866
[TBL] [Abstract][Full Text] [Related]
11. [Celiprolol improves glucose metabolism in essential hypertension].
Oksa A; Fedelesová V; Spustová V; Dzúrik R
Vnitr Lek; 1998 Feb; 44(2):63-7. PubMed ID: 9820078
[TBL] [Abstract][Full Text] [Related]
12. Long-term therapy with terazosin may improve glucose and lipid metabolism in hypertensives: a multicenter prospective study.
Shionoiri H; Gotoh E; Ito T; Hata T; Iwatsubo H; Takegawa K; Ogihara T; Mikami H; Ikegami H; Otsuka A
Am J Med Sci; 1994 Feb; 307 Suppl 1():S91-5. PubMed ID: 7908168
[TBL] [Abstract][Full Text] [Related]
13. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
[TBL] [Abstract][Full Text] [Related]
14. Clinical review of perindopril in the treatment of hypertension.
Lerebours G; Antony I
Can J Cardiol; 1994 Nov; 10 Suppl D():3D-7D. PubMed ID: 7954037
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effects of combination therapy with angiotensin II receptor blocker and angiotensin-converting enzyme inhibitor on vascular endothelial function.
Morimoto S; Maki K; Aota Y; Sakuma T; Iwasaka T
Hypertens Res; 2008 Aug; 31(8):1603-10. PubMed ID: 18971536
[TBL] [Abstract][Full Text] [Related]
16. Once daily perindopril versus slow release diltiazem in the treatment of mild to moderate essential hypertension. Canadian Study Group on Perindopril.
Can J Cardiol; 1994 Nov; 10 Suppl D():8D-12D. PubMed ID: 7954041
[TBL] [Abstract][Full Text] [Related]
17. [Ambulatory registration of arterial pressure during treatment with perindopril. Effects on systolic pressure and hemodynamic implications].
Santoni JP; Asmar RG; Bizot-Espiard JG; Safar M
Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():51-6. PubMed ID: 2505713
[TBL] [Abstract][Full Text] [Related]
18. Perindopril plus nifedipine versus perindopril plus hydrochlorothiazide in mild to severe hypertension: a double-blind multicentre study. The Multicentre Study Group on Treatment Association with Perindopril.
Letellier P; Overlack A; Agnes E; Desche P
J Hum Hypertens; 1994 Feb; 8(2):145-9. PubMed ID: 8207741
[TBL] [Abstract][Full Text] [Related]
19. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
[TBL] [Abstract][Full Text] [Related]
20. Metabolic effects of spirapril and atenolol: results from a randomized, long-term study.
Hakamäki T; Lehtonen A
Int J Clin Pharmacol Ther; 1997 Jun; 35(6):227-30. PubMed ID: 9208336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
